UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Osimertinib in patients with T790M mutation‐positive, advanced non–small cell lung cancer: Long‐term follow‐up from a pooled analysis of 2 phase 2 studies

Cancer, 2019-03, Vol.125 (6), p.892-901

2019

Volltextzugriff (PDF)

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

The lancet oncology, 2015-07, Vol.16 (7), p.830-838

2015

Volltextzugriff (PDF)

The Use of Wearable Devices in Oncology Patients: A Systematic Review

The oncologist (Dayton, Ohio), 2024-04, Vol.29 (4), p.e419-e430

2024

Volltextzugriff (PDF)

Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

European journal of cancer (1990), 2020-01, Vol.124, p.110-122

2020

Volltextzugriff (PDF)

A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia

Clinical cancer research, 2017-02, Vol.23 (4), p.899-907

2017

Volltextzugriff (PDF)

COVID‐19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system

Cancer, 2021-09, Vol.127 (18), p.3466-3475

2021

Volltextzugriff (PDF)

Atypical Teratoid/Rhabdoid Tumor in Taiwan: A Nationwide, Population-Based Study

Cancers, 2022-01, Vol.14 (3), p.668

2022

Volltextzugriff (PDF)

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial

International journal of radiation oncology, biology, physics, 2024-05, Vol.119 (1), p.66-77

2024

Volltextzugriff (PDF)

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

The New England journal of medicine, 2018-01, Vol.378 (4), p.331-344

2018

Volltextzugriff (PDF)

Practical Steps to Mitigate Cybersecurity Attacks on Radiation Oncology Practices

Practical Radiation Oncology, 2023-09, Vol.13 (5), p.429-433

2023

Volltextzugriff (PDF)

Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials

Clinical lung cancer, 2018-07, Vol.19 (4), p.e465-e479

2018

Volltextzugriff (PDF)

Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

Annals of surgical oncology, 2020-10, Vol.27 (11), p.4122-4130

2020

Volltextzugriff (PDF)

Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base

International journal of particle therapy, 2020, Vol.6 (4), p.17-28

2020

Volltextzugriff (PDF)

Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis

International journal of particle therapy, 2022-09, Vol.9 (2), p.40-48

2022

Volltextzugriff (PDF)

Genomic Prediction of Locoregional Recurrence After Mastectomy in Breast Cancer

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4594-4602

2006

Volltextzugriff (PDF)

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Radiotherapy and oncology, 2024-01, Vol.190, p.109977-109977, Article 109977

2024

Volltextzugriff (PDF)

Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers

Journal of thoracic oncology, 2014-06, Vol.9 (6), p.752-759

2014

Volltextzugriff (PDF)

Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials

International journal of radiation oncology, biology, physics, 2001-07, Vol.50 (3), p.717-726

2001

Volltextzugriff (PDF)

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

JAMA network open, 2022-11, Vol.5 (11), p.e2241538

2022

Volltextzugriff (PDF)

A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1

Oncogene, 2010-04, Vol.29 (17), p.2467-2476

2010

Volltextzugriff (PDF)

Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma

JAMA network open, 2023-01, Vol.6 (1), p.e2250607

2023

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Humans
(44)
Middle Aged
(30)
Female
(29)
Adult
(28)
Male
(26)
Aged
(21)
Radiology, Nuclear Medicine & Medical Imaging
(16)
Biological And Medical Sciences
(15)
Radiotherapy
(15)
Medical Sciences
(14)
Chemotherapy
(12)
Neoplasm Staging
(12)
Combined Modality Therapy
(11)
Disease-Free Survival
(11)
Tumors
(11)
Aged, 80 And Over
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Osimertinib in patients with T790M mutation‐positive, advanced non–small cell lung cancer: Long‐term follow‐up from a pooled analysis of 2 phase 2 studies

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

The Use of Wearable Devices in Oncology Patients: A Systematic Review

Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia

Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma

A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer

COVID‐19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system

Atypical Teratoid/Rhabdoid Tumor in Taiwan: A Nationwide, Population-Based Study

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial

Practical Steps to Mitigate Cybersecurity Attacks on Radiation Oncology Practices

Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials

Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base

Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis

Genomic Prediction of Locoregional Recurrence After Mastectomy in Breast Cancer

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers

Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1

Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma

Aktive Filter

Suchergebnisse filtern